| Survival: | ? |
| Toxicity Grade: | 4 |
| Treatments: | Chemotherapy |
| Drugs: | Doxil |
| Country: | United States |
| City/State/Province: | Minneapolis, Minnesota |
| Hospital: | University of Minnesota Medical School |
| Journal: | Link |
| Date: | 1/2002 |
| Description: |
| Patients: This Phase II study involved 15 patients with mesothelioma. Treatment: The treatment consisted of the administration of the drug, doxorubicin (doxil). Toxicity: Toxicities included neutrophils (grade 3 and 4), skin (grade 1 and 2), mucositis (grade 1 and 2), nausea (grade 1), and fatigue (grade 1). Results: One patient had a partial response. Overall survival was not discussed. |